<code id='40D3750B50'></code><style id='40D3750B50'></style>
    • <acronym id='40D3750B50'></acronym>
      <center id='40D3750B50'><center id='40D3750B50'><tfoot id='40D3750B50'></tfoot></center><abbr id='40D3750B50'><dir id='40D3750B50'><tfoot id='40D3750B50'></tfoot><noframes id='40D3750B50'>

    • <optgroup id='40D3750B50'><strike id='40D3750B50'><sup id='40D3750B50'></sup></strike><code id='40D3750B50'></code></optgroup>
        1. <b id='40D3750B50'><label id='40D3750B50'><select id='40D3750B50'><dt id='40D3750B50'><span id='40D3750B50'></span></dt></select></label></b><u id='40D3750B50'></u>
          <i id='40D3750B50'><strike id='40D3750B50'><tt id='40D3750B50'><pre id='40D3750B50'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:791
          The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus
          Summa Health

          General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

          The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

          advertisement

          On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout LOUD podcast, live from the STAT Breakthrough Summit East
          Readout LOUD podcast, live from the STAT Breakthrough Summit East

          Isthereacureforallergies?HastheFDAbecometooflexible?Andwhichdrugsmakeyoumuscular?Wecoverallthatandmo

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Fatty liver disease was alleviated by Lilly’s ‘triple

          Largevacuolesoftriglyceridefat,accumulatedinsidelivercells.AdobeSANDIEGO—Anexperimentalobesitydrugfr